Clinical Pharmacology and Drug Toxicity — MCQs

Clinical Pharmacology and Drug Toxicity Indian Medical PG Practice Questions and MCQs

Question 341: Which of the following drugs inhibits Interleukin-2 (IL-2)?

A. Cycloserine
B. Cyclosporine (Correct Answer)
C. OKT-3
D. All of the above

Explanation: ### Explanation **Correct Answer: B. Cyclosporine** **Mechanism of Action:** Cyclosporine is a potent immunosuppressant belonging to the **Calcineurin Inhibitor** class. Its primary mechanism involves binding to an intracellular protein called **Cyclophilin**. This Cyclosporine-Cyclophilin complex inhibits **Calcineurin**, a phosphatase required for the dephosphorylation of the Nuclear Factor of Activated T-cells (NFAT). Without dephosphorylation, NFAT cannot enter the nucleus to promote the transcription of **Interleukin-2 (IL-2)**. Since IL-2 is the primary cytokine responsible for T-cell proliferation and activation, its inhibition leads to profound immunosuppression. **Analysis of Incorrect Options:** * **A. Cycloserine:** This is a second-line **antitubercular drug** (cell wall synthesis inhibitor). It acts as an analog of D-alanine and inhibits the enzyme alanine racemase. It has no role in IL-2 inhibition. * **C. OKT-3 (Muromonab-CD3):** This is a monoclonal antibody directed against the **CD3 receptor** on the surface of T-lymphocytes. While it causes T-cell depletion and prevents T-cell activation, it does not directly inhibit the synthesis of IL-2 in the same biochemical manner as calcineurin inhibitors. (Note: It is now largely withdrawn due to cytokine release syndrome). **High-Yield Clinical Pearls for NEET-PG:** * **Adverse Effects of Cyclosporine:** Remember the "6 H's": **H**irsutism, **H**yperplasia of gums (gingival hypertrophy), **H**ypertension, **H**yperlipidemia, **H**yperkalemia, and **H**epatotoxicity. Most importantly, it is **Nephrotoxic** (dose-limiting). * **Tacrolimus:** Another calcineurin inhibitor (binds to FKBP-12) that also inhibits IL-2. It is more potent than cyclosporine and does *not* cause hirsutism or gingival hyperplasia, but carries a higher risk of post-transplant diabetes mellitus. * **Sirolimus (Rapamycin):** Unlike cyclosporine, it does not inhibit IL-2 production; instead, it inhibits the **response** to IL-2 by blocking the **mTOR** pathway.

Question 342: Which drug is known to cause peripheral neuropathy?

A. Colchicine
B. Isoniazid
C. Nitrofurantoin
D. All of the above (Correct Answer)

Explanation: **Explanation:** Peripheral neuropathy is a common adverse effect of several pharmacological agents, occurring through various mechanisms such as axonal degeneration, demyelination, or interference with metabolic pathways. **1. Why "All of the above" is correct:** * **Isoniazid (INH):** This is the most high-yield cause of peripheral neuropathy in medical exams. It structurally resembles **Pyridoxine (Vitamin B6)** and promotes its excretion. This deficiency leads to impaired synthesis of neurotransmitters and myelin, resulting in a dose-dependent symmetrical peripheral neuropathy. * **Colchicine:** Used in gout, colchicine inhibits microtubule polymerization by binding to tubulin. Since axonal transport is heavily dependent on microtubules, long-term use or high doses can lead to **neuromyopathy**, characterized by proximal muscle weakness and sensory loss. * **Nitrofurantoin:** Used for UTIs, this drug can cause severe, sometimes irreversible, sensorimotor peripheral neuropathy, especially in patients with **renal impairment** where the drug accumulates to toxic levels. **2. Clinical Pearls for NEET-PG:** * **Prophylaxis:** Isoniazid-induced neuropathy is prevented by co-administering **10–50 mg/day of Pyridoxine**. * **Other High-Yield Drugs causing Peripheral Neuropathy:** * **Chemotherapy:** Vincristine (microtubule inhibitor), Cisplatin, Paclitaxel. * **Antimicrobials:** Ethambutol, Metronidazole, Linezolid, Fluoroquinolones. * **Others:** Amiodarone, Hydralazine, Phenytoin, Gold salts. * **Vincristine** is unique as it often presents with "foot drop" due to its profound effect on microtubule-mediated axonal transport.

Question 343: All of the following predispose to chloroquine toxicity except?

A. Duration of use greater than 2 years (Correct Answer)
B. Cumulative dose greater than 460 g
C. Daily dose greater than 250 mg/day or greater than 3 mg/kg
D. Renal failure

Explanation: **Explanation:** Chloroquine and Hydroxychloroquine are associated with serious **retinal toxicity**. The risk of toxicity is primarily determined by the **cumulative dose** and the **duration of exposure**. According to the American Academy of Ophthalmology (AAO) guidelines, the critical threshold for duration of use is **greater than 5 years**, not 2 years. Therefore, Option A is the correct answer as it is not a standard predisposing factor. **Analysis of Options:** * **Option A (Correct):** Toxicity is rarely seen within the first 5 years of treatment. A duration of >5 years is considered a major risk factor. * **Option B (Incorrect):** A cumulative dose exceeding **460 g** for Chloroquine (or >1000 g for Hydroxychloroquine) significantly increases the risk of irreversible retinopathy. * **Option C (Incorrect):** High daily doses are the most significant predictors of toxicity. For Chloroquine, a dose **>2.3 mg/kg/day** (often rounded to >3 mg/kg or >250 mg/day) is considered high risk. * **Option D (Incorrect):** Since these drugs are cleared renally, **renal failure** increases the elimination half-life, leading to higher systemic levels and increased risk of toxicity. **High-Yield Clinical Pearls for NEET-PG:** * **Bull’s Eye Maculopathy:** The classic presentation of chloroquine retinopathy (bilateral, symmetrical granular pigmentary changes). * **Screening:** Baseline ophthalmic exam is required, followed by annual screening after 5 years of use. * **Mechanism:** Chloroquine binds to melanin in the Retinal Pigment Epithelium (RPE), leading to localized damage. * **Other Toxicities:** Myopathy, cardiomyopathy, and QT prolongation.

Question 344: Bremelanotide is a drug approved for the treatment of which condition?

A. Erectile dysfunction (Correct Answer)
B. Lower urinary tract symptoms
C. Prostate cancer
D. Metastatic renal cancer

Explanation: **Explanation:** **Bremelanotide** is a synthetic peptide analog of the naturally occurring α-melanocyte-stimulating hormone (α-MSH). It acts as a non-selective **Melanocortin Receptor Agonist**, specifically targeting **MC3R and MC4R** in the central nervous system (hypothalamus). Unlike phosphodiesterase-5 (PDE5) inhibitors which act peripherally on vascular smooth muscle, Bremelanotide works centrally to modulate brain pathways involved in sexual desire and arousal. * **Why Option A is correct:** While Bremelanotide was initially investigated for **Erectile Dysfunction (ED)** due to its ability to induce erections via central mechanisms, it is clinically more significant today for its FDA approval in treating **Hypoactive Sexual Desire Disorder (HSDD)** in premenopausal women. In the context of NEET-PG, it is categorized under drugs for sexual dysfunction. * **Why Options B, C, and D are incorrect:** * **Lower Urinary Tract Symptoms (LUTS):** Typically treated with α1-blockers (Tamsulosin) or 5-α reductase inhibitors (Finasteride). * **Prostate Cancer:** Managed with GnRH agonists (Leuprolide), antagonists (Degarelix), or anti-androgens (Enzalutamide). * **Metastatic Renal Cancer:** Treated with Tyrosine Kinase Inhibitors (Sunitinib) or Immunotherapy (Nivolumab). **High-Yield Clinical Pearls for NEET-PG:** 1. **Route of Administration:** Subcutaneous injection (auto-injector) used "on-demand" at least 45 minutes before sexual activity. 2. **Key Side Effect:** Transient **increase in blood pressure** and decrease in heart rate after each dose; hence, it is contraindicated in patients with uncontrolled hypertension. 3. **Skin Changes:** Can cause focal hyperpigmentation (melanocortin effect on MC1R). 4. **Comparison:** Unlike Flibanserin (a 5-HT1A agonist for HSDD), Bremelanotide does not have a major interaction with alcohol.

Question 345: Which one of the following drugs cannot cause Pseudotumour Cerebri?

A. Salicylic acid (Correct Answer)
B. Nalidixic acid
C. Tetracycline
D. Nitrofurantoin

Explanation: **Explanation:** **Pseudotumor Cerebri (PTC)**, also known as Idiopathic Intracranial Hypertension (IIH), is a clinical syndrome characterized by increased intracranial pressure (ICP) in the absence of a space-occupying lesion or hydrocephalus. Certain drugs are well-known triggers for this condition. **1. Why Salicylic acid is the correct answer:** Salicylic acid (Aspirin) is **not** associated with Pseudotumor Cerebri [1, 4]. In fact, high doses of salicylates are more commonly associated with tinnitus, metabolic acidosis, and respiratory alkalosis [1, 4], but they do not interfere with cerebrospinal fluid (CSF) dynamics to cause intracranial hypertension. **2. Why the other options are incorrect:** * **Nalidixic acid (B):** This first-generation quinolone is a classic cause of medication-induced PTC, particularly in the pediatric population. * **Tetracycline (C):** Tetracyclines (including Doxycycline and Minocycline) are the most frequently implicated antibiotics. They are thought to interfere with the resorption of CSF at the arachnoid villi. * **Nitrofurantoin (D):** This urinary antiseptic is a documented, though less common, cause of drug-induced PTC. **Clinical Pearls for NEET-PG:** * **Mnemonic for PTC-causing drugs (PANTS):** **P**henytoin/Prednisone (withdrawal), **A**miodarone/All-trans retinoic acid (Vitamin A), **N**alidixic acid/Nitrofurantoin, **T**etracyclines, **S**teroids (withdrawal). * **Clinical Presentation:** Headache, papilledema, and abducens (6th cranial) nerve palsy. * **Diagnosis:** Lumbar puncture shows elevated opening pressure (>250 mmH2O) with normal CSF composition. * **High-Yield Fact:** While **Steroid use** can cause many side effects [3], it is specifically **Steroid withdrawal** that is most strongly linked to the development of Pseudotumor Cerebri.

Question 346: Which of the following drugs does not cause pancreatitis?

A. Somatostatin (Correct Answer)
B. Azathioprine
C. 1-Asparaginase
D. Furosemide

Explanation: **Explanation:** Drug-induced pancreatitis (DIP) is a significant clinical entity in pharmacology. The correct answer is **Somatostatin**, as it is actually used in the **management** of pancreatitis and its complications (like pancreatic fistulas), rather than being a causative agent. **1. Why Somatostatin is the correct answer:** Somatostatin (and its synthetic analog Octreotide) inhibits the secretion of various hormones and digestive enzymes, including gastrin, cholecystokinin (CCK), and pancreatic enzymes. By reducing pancreatic exocrine secretion, it provides "rest" to the pancreas. Therefore, it does not cause pancreatitis; it is therapeutic. **2. Why the other options are incorrect:** * **Azathioprine:** This is one of the most common causes of drug-induced pancreatitis. It is an immunosuppressant (purine analog) where the reaction is typically hypersensitivity-mediated. * **L-Asparaginase:** Used in Acute Lymphoblastic Leukemia (ALL), this enzyme frequently causes pancreatitis (up to 10% of patients) by interfering with protein synthesis in pancreatic acinar cells. * **Furosemide:** This loop diuretic is a well-known cause of DIP, likely due to its sulfonamide structure causing hypersensitivity or direct toxic effects on the pancreas. **High-Yield Clinical Pearls for NEET-PG:** * **Mnemonic for DIP (FAT SHEEP):** **F**urosemide, **A**zathioprine/Aminosalicylates, **T**etracycline, **S**ulfonamides/Statins, **H**CTZ, **E**strogens, **E**nalapril (ACEi), **P**entamidine/Val**p**roate. * **Didanosine (ddI):** The NRTI most strongly associated with pancreatitis. * **Sodium Valproate:** A common cause of pancreatitis in the pediatric population. * **Corticosteroids:** Though controversial, they are traditionally listed as a potential cause of DIP.

Question 347: Which of the following can cause red cell aplasia?

A. Aminoglycosides
B. Chloramphenicol (Correct Answer)
C. Penicillins
D. Ciprofloxacin

Explanation: **Explanation:** **Chloramphenicol** is a broad-spectrum antibiotic known for its significant hematological toxicities. It causes bone marrow suppression through two distinct mechanisms: 1. **Dose-dependent (Predictable):** It inhibits mitochondrial protein synthesis in the bone marrow, leading to anemia, leukopenia, or thrombocytopenia. This includes **Pure Red Cell Aplasia (PRCA)**, which is reversible upon drug discontinuation. 2. **Idiosyncratic (Unpredictable):** A rare but fatal **Aplastic Anemia** that is dose-independent and can occur weeks or months after therapy. **Analysis of Incorrect Options:** * **Aminoglycosides (e.g., Gentamicin):** These are primarily associated with **nephrotoxicity** (acute tubular necrosis) and **ototoxicity** (vestibular and cochlear damage). They do not typically cause marrow suppression. * **Penicillins:** The most common adverse effect is hypersensitivity (Type I IgE-mediated). While high doses can rarely cause hemolytic anemia (Type II hypersensitivity), they are not associated with red cell aplasia. * **Ciprofloxacin (Fluoroquinolones):** Common side effects include GI upset, tendon rupture/tendonitis, and QTc prolongation. Hematological toxicity is extremely rare. **High-Yield Clinical Pearls for NEET-PG:** * **Gray Baby Syndrome:** Occurs in neonates due to deficient **glucuronyl transferase** enzyme, leading to chloramphenicol accumulation, cyanosis, and circulatory collapse. * **Mechanism of Action:** Chloramphenicol binds to the **50S ribosomal subunit**, inhibiting peptidyl transferase. * **Drug of Choice:** Though limited by toxicity, it remains a backup for enteric fever (Typhoid) and bacterial meningitis in patients with severe penicillin allergies.

Question 348: All of the following can be used in the treatment of metoprolol toxicity EXCEPT?

A. Glucagon
B. Atropine
C. Calcium gluconate
D. Naloxone (Correct Answer)

Explanation: **Explanation:** Metoprolol is a cardioselective $\beta_1$-adrenergic antagonist. Toxicity leads to severe bradycardia, hypotension, and cardiogenic shock due to decreased cAMP levels and reduced intracellular calcium. **Why Naloxone is the correct answer:** **Naloxone** is a competitive opioid receptor antagonist used primarily for opioid overdose. It has no pharmacological role in reversing the effects of beta-blockers. While some studies suggest high-dose naloxone might have a minor effect on shock, it is not a standard or recommended treatment for metoprolol toxicity. **Why the other options are incorrect:** * **Glucagon (Drug of Choice):** It bypasses the blocked $\beta$-receptors and stimulates adenylate cyclase via specific glucagon receptors, increasing cAMP. This exerts positive inotropic and chronotropic effects. * **Atropine:** An anticholinergic used as the first-line agent for symptomatic bradycardia to increase the heart rate by blocking vagal tone. * **Calcium Gluconate:** Used to increase intracellular calcium levels, which helps improve myocardial contractility (inotropy) and counteract the negative inotropic effects of beta-blockers. **High-Yield Clinical Pearls for NEET-PG:** 1. **Glucagon** is the specific antidote for Beta-blocker poisoning. 2. **High-dose Insulin-Euglycemia (HIET)** therapy is another critical management strategy for refractory beta-blocker and calcium channel blocker toxicity. 3. For **Lipid-soluble** beta-blocker toxicity (like Propranolol), **Intravenous Lipid Emulsion (ILE)** can be used as a "lipid sink." 4. If pharmacological measures fail, **Cardiac Pacing** or **ECMO** are the definitive treatments.

Question 349: What is the antidote for belladonna poisoning?

A. Neostigmine
B. Physostigmine (Correct Answer)
C. Pilocarpine
D. Methacholine

Explanation: Belladonna poisoning (Atropine toxicity) is characterized by a "central anticholinergic syndrome." The goal of treatment is to increase acetylcholine levels to overcome the competitive blockade of muscarinic receptors. **Why Physostigmine is the Correct Answer:** Physostigmine is a **tertiary amine** acetylcholinesterase inhibitor. Unlike other carbamates, its lipid solubility allows it to **cross the blood-brain barrier (BBB)**. This is crucial because belladonna alkaloids cause both peripheral (tachycardia, dry skin) and central (delirium, hallucinations, seizures) toxicity. Physostigmine effectively reverses both central and peripheral symptoms. **Why Other Options are Incorrect:** * **Neostigmine:** This is a quaternary ammonium compound. It is polar and **cannot cross the BBB**, meaning it would only treat peripheral symptoms and fail to reverse the life-threatening CNS effects of belladonna. * **Pilocarpine:** While it is a muscarinic agonist, it is primarily used topically in ophthalmology. [2] It is not potent or systemic enough to counteract a massive atropine overdose. * **Methacholine:** This is a synthetic choline ester used mainly for the bronchial challenge test in asthma diagnosis; it has no clinical role in treating systemic anticholinergic poisoning. **High-Yield Clinical Pearls for NEET-PG:** * **Mnemonic for Atropine Toxicity:** "Hot as a hare, Red as a beet, Dry as a bone, Blind as a bat, and Mad as a hatter." * **Physostigmine Caution:** It should be administered via slow IV injection. Rapid administration can cause bradycardia or seizures. It is contraindicated in TCA (Tricyclic Antidepressant) overdose due to increased risk of cardiac arrest. * **Drug of Choice:** While Physostigmine is the specific antidote, the initial management of belladonna poisoning is often supportive (gastric lavage, cooling, and benzodiazepines for seizures). [1]

Question 350: In acute morphine poisoning, what is the drug of choice?

A. Atropine
B. Methadone
C. Naloxone (Correct Answer)
D. Alcohol

Explanation: **Explanation:** **Correct Answer: C. Naloxone** Naloxone is the drug of choice for acute morphine (opioid) poisoning because it is a **pure opioid antagonist**. It has a high affinity for $\mu$, $\kappa$, and $\delta$ opioid receptors, effectively displacing morphine from these sites. It rapidly reverses the life-threatening triad of opioid overdose: **respiratory depression, pinpoint pupils (miosis), and coma.** Because it has no agonist activity, it is safe to administer even if the diagnosis is uncertain. **Why other options are incorrect:** * **Atropine:** This is a muscarinic antagonist. While it can treat bradycardia or organophosphate poisoning, it does not reverse the central nervous system or respiratory depression caused by opioids. * **Methadone:** This is a long-acting opioid agonist. It is used in the **maintenance treatment** of opioid de-addiction to prevent withdrawal symptoms, but it would worsen acute toxicity. * **Alcohol:** Alcohol is a CNS depressant. Co-ingestion with morphine actually potentiates respiratory depression and increases the risk of fatality. **High-Yield Clinical Pearls for NEET-PG:** * **Short Duration of Action:** Naloxone has a shorter half-life (approx. 60–90 mins) than most opioids. Patients must be monitored for **"re-narcotization"** as the antagonist wears off before the agonist. * **Naltrexone vs. Naloxone:** Remember that **Naltrexone** is orally active and long-acting, used for *preventing relapse* in detoxified addicts, whereas **Naloxone** is used for *emergency reversal* (IV/Intranasal). * **Diagnostic Use:** Naloxone is often included in the "coma cocktail" for patients with an unknown cause of unconsciousness.

Practice by Chapter

Principles of Clinical Pharmacology

Practice Questions

Therapeutic Drug Monitoring

Practice Questions

Drug Toxicity and Overdose

Practice Questions

Antidotes and Their Applications

Practice Questions

Management of Drug Poisoning

Practice Questions

Drug-Induced Liver Injury

Practice Questions

Drug-Induced Kidney Injury

Practice Questions

Drug-Induced Blood Dyscrasias

Practice Questions

Drug-Induced QT Prolongation

Practice Questions

Pharmacovigilance

Practice Questions

Want unlimited practice?

Get full access to all questions, explanations, and performance tracking.

Start For Free